Clearwater Capital Advisors’s ImmunityBio IBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.5M	Sell	717,524 -127,560	-15%	-$873K	0.44%	35
2025 Q4	$1.67M	Sell	845,084 -1,335	-0.2%	-$3.02K	0.14%	57
2025 Q3	$2.08M	Hold	846,419	–	–	0.18%	54
2025 Q2	$2.23M	Hold	846,419	–	–	0.2%	52
2025 Q1	$2.55M	Hold	846,419	–	–	0.25%	50
2024 Q4	$2.17M	Buy	846,419 +363,870	+75%	+$1.52M	0.21%	55
2024 Q3	$1.8M	Hold	482,549	–	–	0.17%	59
2024 Q2	$3.05M	Buy	482,549 +39,250	+9%	+$259K	0.32%	45
2024 Q1	$2.38M	Hold	443,299	–	–	0.25%	52
2023 Q4	$2.23M	Buy	443,299 +48,700	+12%	+$153K	0.25%	51
2023 Q3	$667K	Hold	394,599	–	–	0.08%	69
2023 Q2	$1.1M	Buy	394,599 +77,448	+24%	+$219K	0.13%	63
2023 Q1	$577K	Buy	317,151 +131,240	+71%	+$408K	0.07%	83
2022 Q4	$943K	Hold	185,911	–	–	0.12%	71
2022 Q3	$924K	Buy	185,911 +600	+0.3%	+$2.73K	0.13%	78
2022 Q2	$689K	Buy	185,311 +37,420	+25%	+$150K	0.09%	81
2022 Q1	$830K	Buy	147,891 +7,340	+5%	+$45K	0.1%	81
2021 Q4	$855K	Sell	140,551 -7,340	-5%	-$55.1K	0.09%	89
2021 Q3	$1.44M	Buy	147,891 +75,865	+105%	+$835K	0.17%	65
2021 Q2	$1.03M	Hold	72,026	–	–	0.12%	75
2021 Q1	$1.71M	Buy	72,026 +37,971	+111%	+$984K	0.21%	59
2020 Q4	$454K	Buy	+34,055	New	+$328K	0.06%	105